Induced pluripotent stem cells: Developmental biology to regenerative medicine

Timothy J Nelson, Almudena Martinez-Fernandez, Andre Terzic

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Nuclear reprogramming of somatic cells with ectopic stemness factors to bioengineer pluripotent autologous stem cells signals a new era in regenerative medicine. The study of developmental biology has provided a roadmap for cardiac differentiation from embryonic tissue formation to adult heart muscle rejuvenation. Understanding the molecular mechanisms of stem-cell-derived cardiogenesis enables the reproducible generation, isolation, and monitoring of progenitors that have the capacity to recapitulate embryogenesis and differentiate into mature cardiac tissue. With the advent of induced pluripotent stem (iPS) cell technology, patient-specific stem cells provide a reference point to systematically decipher cardiogenic differentiation through discrete stages of development. Interrogation of iPS cells and their progeny from selected cohorts of patients is an innovative approach towards uncovering the molecular mechanisms of disease. Thus, the principles of cardiogenesis can now be applied to regenerative medicine in order to optimize personalized therapeutics, diagnostics, and discovery-based science for the development of novel clinical applications.

Original languageEnglish (US)
Pages (from-to)700-710
Number of pages11
JournalNature Reviews Cardiology
Volume7
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

Developmental Biology
Induced Pluripotent Stem Cells
Regenerative Medicine
Cell Biology
Stem Cells
Rejuvenation
Pluripotent Stem Cells
Embryonic Development
Myocardium
Technology
Therapeutics
Cellular Reprogramming

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Induced pluripotent stem cells : Developmental biology to regenerative medicine. / Nelson, Timothy J; Martinez-Fernandez, Almudena; Terzic, Andre.

In: Nature Reviews Cardiology, Vol. 7, No. 12, 12.2010, p. 700-710.

Research output: Contribution to journalArticle

@article{e364a72abf1443c6856e3cb8441b4b32,
title = "Induced pluripotent stem cells: Developmental biology to regenerative medicine",
abstract = "Nuclear reprogramming of somatic cells with ectopic stemness factors to bioengineer pluripotent autologous stem cells signals a new era in regenerative medicine. The study of developmental biology has provided a roadmap for cardiac differentiation from embryonic tissue formation to adult heart muscle rejuvenation. Understanding the molecular mechanisms of stem-cell-derived cardiogenesis enables the reproducible generation, isolation, and monitoring of progenitors that have the capacity to recapitulate embryogenesis and differentiate into mature cardiac tissue. With the advent of induced pluripotent stem (iPS) cell technology, patient-specific stem cells provide a reference point to systematically decipher cardiogenic differentiation through discrete stages of development. Interrogation of iPS cells and their progeny from selected cohorts of patients is an innovative approach towards uncovering the molecular mechanisms of disease. Thus, the principles of cardiogenesis can now be applied to regenerative medicine in order to optimize personalized therapeutics, diagnostics, and discovery-based science for the development of novel clinical applications.",
author = "Nelson, {Timothy J} and Almudena Martinez-Fernandez and Andre Terzic",
year = "2010",
month = "12",
doi = "10.1038/nrcardio.2010.159",
language = "English (US)",
volume = "7",
pages = "700--710",
journal = "Nature Reviews Cardiology",
issn = "1759-5002",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Induced pluripotent stem cells

T2 - Developmental biology to regenerative medicine

AU - Nelson, Timothy J

AU - Martinez-Fernandez, Almudena

AU - Terzic, Andre

PY - 2010/12

Y1 - 2010/12

N2 - Nuclear reprogramming of somatic cells with ectopic stemness factors to bioengineer pluripotent autologous stem cells signals a new era in regenerative medicine. The study of developmental biology has provided a roadmap for cardiac differentiation from embryonic tissue formation to adult heart muscle rejuvenation. Understanding the molecular mechanisms of stem-cell-derived cardiogenesis enables the reproducible generation, isolation, and monitoring of progenitors that have the capacity to recapitulate embryogenesis and differentiate into mature cardiac tissue. With the advent of induced pluripotent stem (iPS) cell technology, patient-specific stem cells provide a reference point to systematically decipher cardiogenic differentiation through discrete stages of development. Interrogation of iPS cells and their progeny from selected cohorts of patients is an innovative approach towards uncovering the molecular mechanisms of disease. Thus, the principles of cardiogenesis can now be applied to regenerative medicine in order to optimize personalized therapeutics, diagnostics, and discovery-based science for the development of novel clinical applications.

AB - Nuclear reprogramming of somatic cells with ectopic stemness factors to bioengineer pluripotent autologous stem cells signals a new era in regenerative medicine. The study of developmental biology has provided a roadmap for cardiac differentiation from embryonic tissue formation to adult heart muscle rejuvenation. Understanding the molecular mechanisms of stem-cell-derived cardiogenesis enables the reproducible generation, isolation, and monitoring of progenitors that have the capacity to recapitulate embryogenesis and differentiate into mature cardiac tissue. With the advent of induced pluripotent stem (iPS) cell technology, patient-specific stem cells provide a reference point to systematically decipher cardiogenic differentiation through discrete stages of development. Interrogation of iPS cells and their progeny from selected cohorts of patients is an innovative approach towards uncovering the molecular mechanisms of disease. Thus, the principles of cardiogenesis can now be applied to regenerative medicine in order to optimize personalized therapeutics, diagnostics, and discovery-based science for the development of novel clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=78649443533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649443533&partnerID=8YFLogxK

U2 - 10.1038/nrcardio.2010.159

DO - 10.1038/nrcardio.2010.159

M3 - Article

C2 - 20956984

AN - SCOPUS:78649443533

VL - 7

SP - 700

EP - 710

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

SN - 1759-5002

IS - 12

ER -